Immunotherapy Cost in India: A Complete Treatment & Price Guide

What is Immunotherapy?

Immunotherapy is an advanced form of cancer treatment that uses the body’s immune system to fight cancer. It enhances or modifies the immune response to target and destroy cancer cells. The immunotherapy treatment cost in India depends on the drug used, cancer type, and hospital setup.

Types of immunotherapy include:

• Checkpoint Inhibitors (e.g., Nivolumab, Pembrolizumab)
• CAR T-cell Therapy
• Monoclonal Antibodies
• Cancer Vaccines
• Cytokine Therapy

India offers cost-effective options for most of these, making it a hub for patients seeking affordable immunotherapy in India.

Who Should Consider Immunotherapy?

• Patients with Advanced or Metastatic Cancer: Especially lung, melanoma, kidney, head & neck, and certain types of blood cancers.
• Cancer Patients Unresponsive to Chemotherapy or Radiotherapy: Immunotherapy can be used as a second- or third-line treatment.
• Those Eligible for Targeted Drug Therapy: Based on biomarker testing like PD-L1 expression, MSI-H/dMMR status.
• Patients in Clinical Trial Programs: India also hosts numerous immunotherapy trials, which significantly lower costs.

Additional Considerations

• Relapsed Cancer Cases: Immunotherapy is often considered when standard treatments fail, although it may involve higher costs due to the use of advanced diagnostic tests.
• Combination Therapies: Using multiple immunotherapy drugs improves outcomes but raises overall expenses.
• Specialist Referral: Medical oncologists assess suitability and guide treatment planning.
• Clinical Trials: Some patients may have access to low-cost or free immunotherapy through approved trials in India.

Immunotherapy Cost in India at a Glance

The immunotherapy cost in India varies depending on the cancer type, specific drug used (e.g., Nivolumab, Pembrolizumab, Atezolizumab), treatment cycles, hospital type, and oncologist expertise:

• Minimum Cost: INR 3,30,000 (Approx. USD 4,000 per cycle)
• Average Cost: INR 4,50,000 – INR 6,60,000 (Approx. USD 5,500 – USD 8,000 per cycle)
• Maximum Cost: INR 15,00,000+ (Approx. USD 18,000+) for multiple cycles or combination therapy

Factors Affecting Immunotherapy Cost in India

Here are some of the factors affecting immunotherapy cost in India:

• Drug Type and Brand
  • Generic versions are generally less expensive than branded ones.
  • Drugs like Pembrolizumab, Atezolizumab, and Nivolumab cost more.
• Cancer Type and Stage
  • Advanced cancers require prolonged treatment.
  • Some cancers (like lung or renal) respond better to combination immunotherapy.
• Number of Cycles
  • Immunotherapy is usually given every 2–4 weeks over several months.
  • The total cost multiplies with each additional cycle.
• Hospital Type
  • Corporate hospitals tend to charge more.
  • Government or charitable hospitals may offer subsidized or free options.
• Side Effect Management
  • Costs increase if immunotherapy triggers severe immune-related side effects.
  • Includes steroids, hospital stays, lab tests, and organ-specific treatments.
• Diagnostic Testing
  • Biomarker tests like PD-L1, EGFR, MSI/MMR: 10,000–40,000 (USD 120–480)

Know Your Treatment Cost

Get a cost estimate based on your condition and hospital preferences.

Get Cost Estimate WhatsApp Us

City-Wise Immunotherapy Price in India

India vs. Other Countries: Immunotherapy Cost Comparison

India offers affordable immunotherapy with international-standard care, making it an ideal destination for medical tourists seeking high-quality treatment.

Additional Immunotherapy Pre- and Post-Treatment Costs

Pre-Treatment Costs

• Consultation with Oncologist: 1,000 – 3,000 (USD 12 – 36)
• Diagnostic Biomarker Testing (PD-L1, MSI-H): 10,000 – 40,000 (USD 120 – 480)
• Imaging (CT/PET/MRI): 5,000 – 25,000 (USD 60 – 300)
• Lab Panels & Organ Function: 2,000 – 10,000 (USD 24 – 120)

Post-Treatment & Side Effect Management

• Immune suppression drugs: 10,000 – 30,000/month (USD 120 – 360)
• Hospital Readmission (if complications arise): 50,000 – 3,00,000 (USD 600 – 3,600)
• Long-term follow-ups: 1,000 – 3,000 per visit (USD 12 – 36) 

Note: Hospital Readmissions due to infections or side effects can significantly increase overall expenses.

Know Your Treatment Cost

Get a cost estimate based on your condition and hospital preferences.

Get Cost Estimate WhatsApp Us

Insurance and Financing Options

Most Indian insurers now cover immunotherapy treatment costs under comprehensive oncology plans. Patients should confirm:

• Drug limits or exclusions (mainly imported brands)
• Cycle caps
• ICU and emergency admission coverage

Several hospitals offer EMI options, sometimes at zero interest, especially for treatments exceeding INR 5 Lakhs (approximately USD 6,000).

Tips to Reduce Immunotherapy Cost in India

• Utilize Generic Immunotherapy Drugs: Locally manufactured biosimilars can reduce costs by up to 60%.
• Seek Government Schemes & NGO Aid: Ayushman Bharat, Tata Trusts, and other programs assist with high-cost treatments.
• Plan Cycles Wisely: Utilize club diagnostics, treatment cycles, and reviews to avoid unnecessary hospital charges.
• Choose Package-Based Hospitals: Many hospitals offer immunotherapy packages that cover 4–6 cycles at bundled rates.

Why Choose MediJourney for Immunotherapy Treatment in India?

MediJourney connects patients with India’s top oncology centers offering personalized immunotherapy care for a wide range of cancers. Our services are designed to make the immunotherapy cost in India transparent, predictable, and accessible.

We provide:

• Clear, transparent cost structures with zero hidden fees
• Access to internationally trained oncologists and cancer specialists
• Expert guidance on drug selection and immunotherapy cycle planning
• Financial assistance and treatment financing support for those seeking affordable immunotherapy in India
• End-to-end support including visa facilitation, logistics, and post-treatment care

MediJourney helps patients understand the immunotherapy treatment cost in India, compare the immunotherapy price in India, and explore the immunotherapy treatment package cost in India. All care plans are tailored to individual needs, with clarity on the factors that affect immunotherapy costs in India, to support better decision-making.

FAQs About Immunotherapy Cost in India

Q1. How does the specific immunotherapy drug used affect the overall cost?

Answer: The type of drug is a major cost factor. For instance, Nivolumab and Pembrolizumab are more expensive than monoclonal antibodies or vaccines. Branded imports cost more than generics.

Q2. What is the cost of combination immunotherapy treatments in India?

Answer: Combination therapy can cost between INR 8,00,000 and 20,00,000 (USD 9,600 – 24,000), depending on cancer type, drugs used, and duration.

Q3. What are the costs associated with managing potential side effects or complications of immunotherapy?

Answer: Immune-related adverse events can lead to hospital stays, costing INR 50,000 – 3,00,000 (USD 600 – 3,600). Patients may need immunosuppressants and ICU care.

Q4. Are clinical trials for immunotherapy available in India, and what are the costs involved?

Answer: Yes, major cancer hospitals and research institutes offer clinical trials. Costs are often minimal or free, but eligibility and access depend on the type, stage, and profile of the patient's cancer.